Showing results (531-540 of 615) with videos related to
Sort By:
Pageof 62
International Journal of Behavioral Medicine|October 16, 2012
Pre-biopsy psychological factors predict patient biopsy experienceSarah J Miller, Stephanie J Sohl, Julie B Schnur, et al.Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|June 24, 2008
Cervical intraepithelial neoplasia treatment in Human Immunodeficiency Virus-positive womenS Shah, H Montgomery, J C Crow, et al.Journal of Behavioral Medicine|June 5, 2003
Sources of anticipatory distress among breast surgery patientsGuy H Montgomery, Daniel David, Alisan B Goldfarb, et al.Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|February 16, 1999
Patients' pretreatment expectations of chemotherapy-related nausea are an independent predictor of anticipatory nauseaG H Montgomery, N Tomoyasu, D H Bovbjerg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Randomized controlled trial of a cognitive-behavioral therapy plus hypnosis intervention to control fatigue in patients undergoing radiotherapy for breast cancerGuy H Montgomery, Daniel David, Maria Kangas, et al.Plastic and Reconstructive Surgery|December 3, 2010
Clarifying the expectations of patients undergoing implant breast reconstruction: a qualitative studyLaura Snell, Colleen McCarthy, Anne Klassen, et al.Journal of the American Dietetic Association|October 1, 1994
Reducing the fat content of ground beef in a school foodservice settingM P Snyder, E Obarzanek, D H Montgomery, et al.Foot & Ankle International|August 28, 2020
Indications for Deltoid and Spring Ligament Reconstruction in Progressive Collapsing Foot DeformityJonathan T Deland, Scott J Ellis, Jonathan Day, et al.Foot & Ankle International|August 27, 2020
Consensus for the Indication of a Medializing Displacement Calcaneal Osteotomy in the Treatment of Progressive Collapsing Foot DeformityLew C Schon, Cesar de Cesar Netto, Jonathan Day, et al.European Journal of Cancer (Oxford, England : 1990)|November 29, 2011
A phase II study of ¹⁸F-fluorodeoxyglucose PET-CT in non-small cell lung cancer patients receiving erlotinib (Tarceva); objective and symptomatic responses at 6 and 12 weeksM E R O'Brien, J S Myerson, J I G Coward, et al.Pageof 62